Those findings summarize the role of PGRN as a distinct regulator of cell cycle kinetics and proliferative homeostasis influencing both the S and M phases independently from other growth factors, indirectly explaining its increased expression in a variety of human cancers and tumour cell lines [21,22]. Here, GRN is linked to neoplasm.